IN-VIVO AND IN-VITRO EFFECTS OF MUSCARINIC RECEPTOR ANTAGONISTS ON CONTRACTIONS AND RELEASE OF [H-3] ACETYLCHOLINE IN THE RABBIT URINARY-BLADDER

被引:72
作者
TOBIN, G [1 ]
SJOGREN, C [1 ]
机构
[1] PERSTORP PHARMA, IDEON, LUND, SWEDEN
关键词
URINARY BLADDER; RABBIT; MUSCARINIC RECEPTOR SUBTYPE; CONTRACTILE RESPONSE; ACETYLCHOLINE RELEASE; MUSCARINIC RECEPTOR ANTAGONIST;
D O I
10.1016/0014-2999(95)00221-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The functional effects of muscarinic receptor antagonists were examined in vivo and in vitro on the rabbit urinary bladder. Inhibitory effects on carbachol-evoked contractions of detrusor strips were pronounced for 4-diphenylacetoxy-N-methylpiperidine (4-DAMP; -logIC(50): 8.64), p-fluoro-hexahydro-sila-diphenidol (pFHHSiD; 7.84) and atropine (8.27), while they were less pronounced for pirenzepine (6.62) and methoctramine (5.36). 4-DAMP and methoctramine increased H-3 overflow from [H-3]choline-labelled strips in response to electrical stimulation, contrary to pirenzepine, which decreased the overflow. Concomitant contractions were markedly reduced by 4-DAMP and by pirenzepine, but not by methoctramine. The -logIC(50) estimations for atropine-sensitive electrically evoked contractions revealed methoctramine (4.85) to be less potent on nerve-evoked contractions than on carbachol-evoked contractions, in contrast to pirenzepine (7.15) and 4-DAMP (9.15). The effects of the antagonists in anaesthetized rabbits resembled those in vitro. Thus, muscarinic receptors in the rabbit urinary bladder are heterogeneous; prejunctional facilitatory (M(1)) and inhibitory (M(2)) for acetylcholine release, and postjunctional muscarinic M(3) receptors mediating contractile responses.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 31 条
[1]   ASPECTS ON THE PHYSIOLOGY AND PHARMACOLOGY OF THE BLADDER AND URETHRA [J].
ANDERSSON, KE ;
SJOGREN, C .
PROGRESS IN NEUROBIOLOGY, 1982, 19 (1-2) :71-89
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]   A FURTHER SEARCH FOR SELECTIVE ANTAGONISTS AT M2-MUSCARINIC RECEPTORS [J].
BARLOW, RB ;
SHEPHERD, MK .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (04) :837-843
[4]   COMPARISON OF MUSCARINIC ACETYLCHOLINE BINDING IN THE URINARY-BLADDER AND SUBMANDIBULAR-GLAND OF THE RABBIT [J].
BATRA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 138 (01) :83-88
[5]  
DAGOSTINO G, 1986, J PHARMACOL EXP THER, V239, P522
[6]  
DAGOSTINO G, 1989, N-S ARCH PHARMACOL, V340, P76
[7]  
DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257
[8]  
DORJE F, 1991, J PHARMACOL EXP THER, V256, P727
[9]   THE INTERACTION OF METHOCTRAMINE AND HIMBACINE AT ATRIAL, SMOOTH-MUSCLE AND ENDOTHELIAL MUSCARINIC RECEPTORS INVITRO [J].
EGLEN, RM ;
MONTGOMERY, WW ;
DAINTY, IA ;
DUBUQUE, LK ;
WHITING, RL .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1031-1038
[10]   HETEROGENEITY OF VASCULAR MUSCARINIC RECEPTORS [J].
EGLEN, RM ;
WHITING, RL .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1990, 10 (04) :233-245